These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 23969185)
61. Elevation of antimüllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin. Liu XY; Yang YJ; Tang CL; Wang K; Chen JJ; Teng XM; Ruan YC; Yang JZ Fertil Steril; 2019 Jan; 111(1):157-167. PubMed ID: 30477916 [TBL] [Abstract][Full Text] [Related]
62. Anti-Müllerian hormone and its receptor are detected in most gonadotropin-releasing-hormone cell bodies and fibers in heifer brains. Kereilwe O; Kadokawa H Domest Anim Endocrinol; 2020 Jul; 72():106432. PubMed ID: 32169754 [TBL] [Abstract][Full Text] [Related]
63. PCOS and peripheral AMH levels in relation to FSH receptor gene single nucleotide polymorphisms. Mohiyiddeen L; Salim S; Mulugeta B; McBurney H; Newman WG; Pemberton P; Nardo LG Gynecol Endocrinol; 2012 May; 28(5):375-7. PubMed ID: 22429116 [TBL] [Abstract][Full Text] [Related]
64. Most Cleaved Anti-Müllerian Hormone Binds Its Receptor in Human Follicular Fluid but Little Is Competent in Serum. Pierre A; Racine C; Rey RA; Fanchin R; Taieb J; Cohen-Tannoudji J; Carmillo P; Pepinsky RB; Cate RL; di Clemente N J Clin Endocrinol Metab; 2016 Dec; 101(12):4618-4627. PubMed ID: 27623067 [TBL] [Abstract][Full Text] [Related]
65. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome. Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474 [TBL] [Abstract][Full Text] [Related]
66. AMH and AMHR2 mutations: A spectrum of reproductive phenotypes across vertebrate species. Mullen RD; Ontiveros AE; Moses MM; Behringer RR Dev Biol; 2019 Nov; 455(1):1-9. PubMed ID: 31301298 [TBL] [Abstract][Full Text] [Related]
67. The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome. Qi X; Pang Y; Qiao J Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():82-7. PubMed ID: 26914398 [TBL] [Abstract][Full Text] [Related]
68. [Relationship between single nucleotide polymorphism-56 of calpain-10 gene and glucose and lipid metabolism in polycystic ovary syndrome patients]. Diao XH; Shi YH; Gao Q; Wang LC; Tang R; Chen ZJ Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):106-9. PubMed ID: 18683748 [TBL] [Abstract][Full Text] [Related]
69. Association of adiponectin and resistin gene polymorphisms in South Indian women with polycystic ovary syndrome. Nambiar V; Vijesh VV; Lakshmanan P; Sukumaran S; Suganthi R Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():82-8. PubMed ID: 26995146 [TBL] [Abstract][Full Text] [Related]
70. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome]. Li Y; Wei LN; Xiong YL; Liang XY Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609 [TBL] [Abstract][Full Text] [Related]
71. Higher luteinizing hormone levels associated with antimüllerian hormone in postmenarchal daughters of women with polycystic ovary syndrome. Crisosto N; Ladrón de Guevara A; Echiburú B; Maliqueo M; Cavada G; Codner E; Paez F; Sir-Petermann T Fertil Steril; 2019 Feb; 111(2):381-388. PubMed ID: 30527840 [TBL] [Abstract][Full Text] [Related]
72. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome. Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139 [TBL] [Abstract][Full Text] [Related]
73. Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome. Evliyaoglu O; Imöhl M; Weiskirchen R; van Helden J Clin Chem Lab Med; 2020 Jul; 58(8):1291-1301. PubMed ID: 32069226 [TBL] [Abstract][Full Text] [Related]
74. Expression of anti-Müllerian hormone in two rat models of polycystic ovary syndrome. Du DF; Li XL; Zheng SH J Obstet Gynaecol Res; 2016 Dec; 42(12):1761-1767. PubMed ID: 27718294 [TBL] [Abstract][Full Text] [Related]
75. The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome. Lin S; Huiya Z; Bo L; Wei W; Yongmei G Endocrine; 2009 Dec; 36(3):503-9. PubMed ID: 19856137 [TBL] [Abstract][Full Text] [Related]
76. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins. Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369 [TBL] [Abstract][Full Text] [Related]
77. Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. Laven JS; Mulders AG; Visser JA; Themmen AP; De Jong FH; Fauser BC J Clin Endocrinol Metab; 2004 Jan; 89(1):318-23. PubMed ID: 14715867 [TBL] [Abstract][Full Text] [Related]
78. Serum luteinizing hormone level and luteinizing hormone/follicle-stimulating hormone ratio but not serum anti-Müllerian hormone level is related to ovarian volume in Korean women with polycystic ovary syndrome. Chun S Clin Exp Reprod Med; 2014 Jun; 41(2):86-91. PubMed ID: 25045633 [TBL] [Abstract][Full Text] [Related]
79. Serum anti-Mullerian hormone production is not correlated with seasonal fluctuations of vitamin D status in ovulatory or PCOS women. Pearce K; Gleeson K; Tremellen K Hum Reprod; 2015 Sep; 30(9):2171-7. PubMed ID: 26202912 [TBL] [Abstract][Full Text] [Related]
80. rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in Saudi women. Albalawi FS; Daghestani MH; Daghestani MH; Eldali A; Warsy AS J Biomed Sci; 2018 May; 25(1):50. PubMed ID: 29848339 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]